Detalhe da pesquisa
1.
Deep learning identifies synergistic drug combinations for treating COVID-19.
Proc Natl Acad Sci U S A
; 118(39)2021 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34526388
2.
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Proc Natl Acad Sci U S A
; 117(49): 31365-31375, 2020 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33229545
3.
Synergistic and Antagonistic Drug Combinations against SARS-CoV-2.
Mol Ther
; 29(2): 873-885, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33333292
4.
Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection.
Bioorg Med Chem Lett
; 40: 127906, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33689873
5.
Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate.
Cell
; 158(4): 916-928, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25126794
6.
Genome-wide profiling of chromosome interactions in Plasmodium falciparum characterizes nuclear architecture and reconfigurations associated with antigenic variation.
Mol Microbiol
; 90(3): 519-37, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23980881
7.
Small Molecule Antiviral Compound Collection (SMACC): a database to support the discovery of broad-spectrum antiviral drug molecules.
bioRxiv
; 2022 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35860225
8.
A platform of assays for the discovery of anti-Zika small-molecules with activity in a 3D-bioprinted outer-blood-retina model.
PLoS One
; 17(1): e0261821, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35041689
9.
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike.
bioRxiv
; 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34729560
10.
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike.
PLoS One
; 17(8): e0272364, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947606
11.
Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model.
Proc Natl Acad Sci U S A
; 115(49): 12513-12518, 2018 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30455312
12.
Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites.
Sci Rep
; 11(1): 2121, 2021 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483532
13.
Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite Plasmodium falciparum and Optimization Efforts.
J Med Chem
; 64(4): 2291-2309, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33573376
14.
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19.
ACS Cent Sci
; 6(5): 672-683, 2020 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32483554
15.
Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19.
ACS Cent Sci
; 6(6): 1009, 2020 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32607448
16.
Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay.
bioRxiv
; 2020 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577632
17.
Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay.
ACS Pharmacol Transl Sci
; 3(6): 1352-1360, 2020 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33330843
18.
Discovery of Synergistic and Antagonistic Drug Combinations against SARS-CoV-2 In Vitro.
bioRxiv
; 2020 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32637956
19.
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2.
Front Pharmacol
; 11: 592737, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33708112
20.
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2.
bioRxiv
; 2020 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839771